Data & ReproDrug Discovery & CheminformaticsFreedomIntelligence/OpenClaw-Medical-SkillsData & Reproduction
TO

tooluniverse-pharmacovigilance

Maintainer FreedomIntelligence · Last updated April 1, 2026

Analyze drug safety signals from FDA adverse event reports, label warnings, and pharmacogenomic data. Calculates disproportionality measures (PRR, ROR), identifies serious adverse events, assesses pharmacogenomic risk variants. Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

OpenClawNanoClawAnalysisReproductiontooluniverse-pharmacovigilance🏥 medical & clinicalmedical toolsanalyze

Original source

FreedomIntelligence/OpenClaw-Medical-Skills

https://github.com/FreedomIntelligence/OpenClaw-Medical-Skills/tree/main/skills/tooluniverse-pharmacovigilance

Maintainer
FreedomIntelligence
License
MIT
Last updated
April 1, 2026

Skill Snapshot

Key Details From SKILL.md

2 min

Key Notes

  • Systematic drug safety analysis using FAERS adverse event data, FDA labeling, PharmGKB pharmacogenomics, and clinical trial safety signals.
  • KEY PRINCIPLES: 1. Report-first approach - Create report file FIRST, update progressively 2. Signal quantification - Use disproportionality measures (PRR, ROR) 3. Severity stratification - Prioritize serious/fatal events 4. Multi-source triangulation - FAERS, labels, trials, literature 5. Pharmacogenomic context - Include genetic risk factors 6. Actionable output - Risk-benefit summary with recommendations 7. English-first queries - Always use English drug names and search terms in tool calls, even if the user writes in another language. Only try original-language terms as a fallback. Respond in the user's language.

Source Doc

Excerpt From SKILL.md

When to Use

Apply when user asks:

  • "What are the safety concerns for [drug]?"
  • "What adverse events are associated with [drug]?"
  • "Is [drug] safe? What are the risks?"
  • "Should I be concerned about [specific adverse event] with [drug]?"
  • "Compare safety profiles of [drug A] vs [drug B]"
  • "Pharmacovigilance analysis for [drug]"

1. Report-First Approach (MANDATORY)

  1. Create the report file FIRST:

    • File name: [DRUG]_safety_report.md
    • Initialize with all section headers
    • Add placeholder text: [Researching...]
  2. Progressively update as you gather data

  3. Output separate data files:

    • [DRUG]_adverse_events.csv - Ranked AEs with counts/signals
    • [DRUG]_pharmacogenomics.csv - PGx variants and recommendations

2. Citation Requirements (MANDATORY)

Every safety signal MUST include source:

Use cases

  • Use when asked about drug safety, adverse events, post-market surveillance, or risk-benefit assessment.

Not for

  • Do not rely on this catalog entry alone for installation or maintenance details.

Related skills

Related skills

Back to directory
AA
Data & ReproDrug Discovery & Cheminformatics

aav-vector-design-agent

AAV vector design: capsid selection, promoter optimization, payload capacity.

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView
AG
Data & ReproDrug Discovery & Cheminformatics

agentd-drug-discovery

AgentD autonomous drug discovery: target identification, hit finding, ADMET optimization.

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView
BI
Data & ReproDrug Discovery & Cheminformatics

bio-clinical-databases-hla-typing

Call HLA alleles from NGS data using OptiType, HLA-HD, or arcasHLA for immunogenomics applications. Use when determining HLA genotype for tr…

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView
BI
Data & ReproDrug Discovery & Cheminformatics

bio-clinical-databases-pharmacogenomics

Query PharmGKB and CPIC for drug-gene interactions, pharmacogenomic annotations, and dosing guidelines. Use when predicting drug response fr…

OpenClawNanoClawAnalysis
FreedomIntelligence/OpenClaw-Medical-SkillsView